Naquila, Madelyn C.
HRN: 23 06 49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
05/25/2023
06/01/2023
PO
1/2 Dropper
Q4H Waking Hours
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes